scanance.
Sign inGet Premium
EL

EssilorLuxottica Société anonyme

EL.PAHealthcareEURONEXT

Medical Instruments & Supplies

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot
MA150-27.07%
$239.68

Price below medium-term moving average.

MA200-29.08%
$246.48

Below long-term trend line.

RSI-14neutral
44.6

Balanced. Not overbought, not oversold.

MACDpositive
+1.1870

Histogram positive — upward momentum.

Financials · Annual
Revenue
$28.49B
+7.5% YoY
Net Income
$2.31B
-1.9% YoY
EBITDA
$6.60B
+0.1% YoY
Free Cash Flow
$3.28B

Scan Results

Daily timeframe
DateIndicatorDetails
Loading...
About EssilorLuxottica Société anonyme

EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, sunglasses, and instruments and equipment in North America, the Middle East, Africa, Europe, Latin. Valued at $80.28B, EL.PA is a large-cap name in its sector. It offers lens, eyewear, contact lenses, reading glasses under Essilor, Varilux, Crizal, Eyezen, Stellest, Xperio, Transitions, Ray-Ban, Oakley, Barberini, KODAK Lens, Nikon, Shamir Optical, eyexpert, iWear, Humanware, Optifog, Persol, Oliver Peoples, Vogue Eyewear, Arnette, Alain Mikli, Costa, Bliz, Native Eyewear and Bolon, and Foster Grant brands.

Key stats
Market Cap$80.28B
P/E (TTM)35.10
Fwd P/E20.70
EPS$4.98
Beta0.54
52W Change-28.6%
Dividend Yield2.29%
ROE6.1%
Analysis

The company holds $3.54B in cash, though total debt stands at $14.40B. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Free cash flow comes in at $3.28B, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. Return on equity stands at 6.1%, which is modest for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 3.4% is on the lower side, which is common in asset-heavy industries. Revenue has been uneven over recent years, ranging from $24.49B to $28.49B.

With a beta below 0.7, EssilorLuxottica Société anonyme typically sees smaller price swings than the overall market, offering a degree of stability during turbulent periods. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing EL.PA.

Links
Not financial advice. Scanance is an educational tool. Past performance does not guarantee future results.PrivacyTerms